Aethlon Medical aims to conduct $12.5 million at-the-market financing

H.C. Wainwright helps raise proceeds for general corporate purposes

By Devika Patel

Knoxville, Tenn., June 28 – Aethlon Medical, Inc. arranged a $12.5 million at-the-market agreement for up to 3 million common shares with H.C. Wainwright & Co., LLC on June 28, according to a prospectus supplement and 8-K filed Tuesday with the Securities and Exchange Commission.

H.C. Wainwright will be paid a 3% commission.

Proceeds will be used for general corporate purposes.

Aethlon, based in San Diego, develops therapeutic medical devices to treat viral infections.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.